Drug Shortage Report for PIPERACILLIN AND TAZOBACTAM FOR INJECTION

Last updated on 2023-05-25 History
Report ID 176000
Drug Identification Number 02521539
Brand name PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Common or Proper name PIPERACILLIN AND TAZOBACTAM
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) TAZOBACTAM PIPERACILLIN
Strength(s) 4.5G 36G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size 1PSOIJ
ATC code J01CR
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-11-23
Estimated end date 2023-05-26
Actual end date 2023-05-22
Shortage status Resolved
Updated date 2023-05-25
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2023-05-25 French Compare
v13 2023-05-25 English Compare
v12 2023-05-15 French Compare
v11 2023-05-15 English Compare
v10 2023-03-13 French Compare
v9 2023-03-13 English Compare
v8 2023-03-06 French Compare
v7 2023-03-06 English Compare
v6 2023-01-19 French Compare
v5 2023-01-19 English Compare
v4 2022-12-28 French Compare
v3 2022-12-28 English Compare
v2 2022-11-28 French Compare
v1 2022-11-28 English Compare

Showing 1 to 14 of 14